Wang W, Yan X, Cheng Z, Zhang Q, et al. Efficacy and safety of adding once-weekly dulaglutide to basal insulin for inadequately controlled type 2 diabetes in Chinese patients (AWARD-CHN3): A randomized, double-blind, placebo-controlled, phase III trial. Diabetes Obes Metab 2023 Sep 21. doi: 10.1111/dom.15263.
PMID: 37732487